Betrosian AP - Search Results

1

High-dose ampicillin-sulbactam as an alternative treatment of late-onset VAP from multidrug-resistant Acinetobacter baumannii.

Betrosian AP, Frantzeskaki F, Xanthaki A, Georgiadis G. Betrosian AP, et al. Scand J Infect Dis. 2007;39(1):38-43. doi: 10.1080/00365540600951184. Scand J Infect Dis. 2007. PMID: 17366011 Clinical Trial.

2

Efficacy and safety of high-dose ampicillin/sulbactam vs. colistin as monotherapy for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia.

Betrosian AP, Frantzeskaki F, Xanthaki A, Douzinas EE. Betrosian AP, et al. J Infect. 2008 Jun;56(6):432-6. doi: 10.1016/j.jinf.2008.04.002. Epub 2008 May 23. J Infect. 2008. PMID: 18501431 Clinical Trial.

3

Bacterial sepsis-induced rhabdomyolysis.

Betrosian A, Thireos E, Kofinas G, Balla M, Papanikolaou M, Georgiadis G. Betrosian A, et al. Intensive Care Med. 1999 May;25(5):469-74. doi: 10.1007/s001340050882. Intensive Care Med. 1999. PMID: 10401940

4

Meningococcal purpura fulminans in a patient with systemic lupus erythematosus: a mimic for catastrophic antiphospholipid antibody syndrome?

Betrosian AP, Balla M, Papanikolaou M, Christopoulou M, Kitsios A, Farmakis E, Georgiadis G. Betrosian AP, et al. Am J Med Sci. 2004 Jun;327(6):373-5. doi: 10.1097/00000441-200406000-00016. Am J Med Sci. 2004. PMID: 15201656

5

Ampicillin-sulbactam: an update on the use of parenteral and oral forms in bacterial infections.

Betrosian AP, Douzinas EE. Betrosian AP, et al. Expert Opin Drug Metab Toxicol. 2009 Sep;5(9):1099-112. doi: 10.1517/17425250903145251. Expert Opin Drug Metab Toxicol. 2009. PMID: 19621991 Review.

6

Hepatotoxicity and valproate therapy.

Betrosian A, Frantzeskaki F. Betrosian A, et al. Intern Med J. 2006 Nov;36(11):752-4. doi: 10.1111/j.1445-5994.2006.01183.x. Intern Med J. 2006. PMID: 17040368 No abstract available.

7

Ecthyma gangrenosum: a rare manifestation of Pseudomonas aeruginosa sepsis in a critically ill adult patient.

Frantzeskaki F, Betrosian AP. Frantzeskaki F, et al. Among authors: betrosian ap. Eur J Dermatol. 2008 May-Jun;18(3):345-6. doi: 10.1684/ejd.2008.0405. Epub 2008 May 13. Eur J Dermatol. 2008. PMID: 18474472 No abstract available.

8

Oral atovaquone for the treatment of severe Pneumocystis jirovecii pneumonia in a patient with glucose-6-phosphate dehydrogenase deficiency.

Douzinas EE, Flevari K, Andrianakis I, Betrosian AP. Douzinas EE, et al. Among authors: betrosian ap. Scand J Infect Dis. 2010;42(1):76-8. doi: 10.3109/00365540903321606. Scand J Infect Dis. 2010. PMID: 19883154

9

Myoglobinemia and propofol infusion.

Betrosian AP, Papanikoleou M, Frantzeskaki F, Diakalis C, Georgiadis G. Betrosian AP, et al. Acta Anaesthesiol Scand. 2005 May;49(5):720. doi: 10.1111/j.1399-6576.2005.00569.x. Acta Anaesthesiol Scand. 2005. PMID: 15836692 No abstract available.

10

Comment on: "The effects of supra-normal protein C levels on markers of coagulation, fibrinolysis and inflammation in a human model of endotoxemia" by Spiel et al.

Messaris E, Memos N, Frantzeskaki F, Economou V, Betrosian A. Messaris E, et al. Thromb Haemost. 2006 Jun;95(6):1048-9. doi: 10.1160/TH06-03-0142. Thromb Haemost. 2006. PMID: 16732392 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

46 results

Search Page